表紙
市場調査レポート

市中肺炎(CAP):世界の治験レビュー

Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 320348
出版日 ページ情報 英文 103 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
市中肺炎(CAP):世界の治験レビュー Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014
出版日: 2014年11月28日 ページ情報: 英文 103 Pages
概要

市中肺炎(CAP)は、臨床医が対処する、最も一般的な感染症の1つです。CAPは、世界における死亡率と罹患率の重要な原因です。多くの病原体は、CAPを引き起こす可能性があります。症状を引き起こす代表的な細菌性病原体は、肺炎球菌(ペニシリン感受性、ペニシリン耐性株)、インフルエンザ菌(アンピシリン感受性、アンピシリン耐性株)、モラクセラ・カタラーリス(すべてはペニシリン耐性株)です。これら3つの病原体で、CAPの症例の約85%を占めています。CAPは通常、肺の1区域か肺葉に、肺の病原性細菌を吸入または吸引することで感染します。頻度は低いものの、大腸菌の尿路感染症や菌血症など、離れた場所の二次菌血症の結果として生じることもあります。誤嚥性肺炎は、複数の病原体(例えば、好気性/嫌気性の経口生物)に起因するCAPの唯一の形態です。

当レポートでは、市中肺炎(CAP)の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:感染性疾患の治験に対する市中肺炎(CAP)の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:感染性疾患の治験に対する市中肺炎(CAP)の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • 市中肺炎(CAP)の治療薬の治験に参加している主要企業

有望薬

治験プロファイル

  • 主要企業の治験概要
    • Pfizer Inc.
    • TaiGen Biopharmaceuticals Holdings Limited
    • Sanofi
    • Actavis plc
    • Bayer AG
    • Melinta Therapeutics, Inc
    • Novartis AG
    • GlaxoSmithKline plc
    • AstraZeneca PLC
    • Abbott Laboratories
  • 主要大学・研究機関・病院の治験概要
    • St. Antonius Hospital
    • University Hospital Basel
    • University of Milan
    • HaEmek Medical Center
    • Medical Center Alkmaar
    • Spanish National Health System
    • Carlos III Health Institute
    • Nagasaki Evaluation Organization for Clinical Interventions
    • 小野市立小野市民病院
    • University of Roma La Sapienza

主な臨床プロファイル

付録

図表

目次
Product Code: GDHC2435CTIDB

GlobalData's clinical trial report, "Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community Acquired Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community Acquired Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community Acquired Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Community Acquired Pneumonia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Community Acquired Pneumonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Community Acquired Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Community Acquired Pneumonia
    • Oct 03, 2014: FDA Grants Durata Therapeutics a Special Protocol Agreement for Its Phase 3 Study of DALVANCE in Hospitalized Community-Acquired Pneumonia
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • TaiGen Biopharmaceuticals Holdings Limited
      • Clinical Trial Overview of TaiGen Biopharmaceuticals Holdings Limited
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Melinta Therapeutics, Inc
      • Clinical Trial Overview of Melinta Therapeutics, Inc
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
    • Clinical Trial Overview of Top Institutes / Government
      • St. Antonius Hospital
      • Clinical Trial Overview of St. Antonius Hospital
      • University Hospital Basel
      • Clinical Trial Overview of University Hospital Basel
      • University of Milan
      • Clinical Trial Overview of University of Milan
      • HaEmek Medical Center
      • Clinical Trial Overview of HaEmek Medical Center
      • Medical Center Alkmaar
      • Clinical Trial Overview of Medical Center Alkmaar
      • Spanish National Health System
      • Clinical Trial Overview of Spanish National Health System
      • Carlos III Health Institute
      • Clinical Trial Overview of Carlos III Health Institute
      • Nagasaki Evaluation Organization for Clinical Interventions
      • Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions
      • Ono Municipal Hospital
      • Clinical Trial Overview of Ono Municipal Hospital
      • University of Roma La Sapienza
      • Clinical Trial Overview of University of Roma La Sapienza
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by TaiGen Biopharmaceuticals Holdings Limited, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Melinta Therapeutics, Inc, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Center Alkmaar, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spanish National Health System, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Carlos III Health Institute, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Municipal Hospital, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Roma La Sapienza, 2014*

List of Figures

  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top